GB0907347D0 - N-(2-aminophenyl)-4[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamid e(MS-275)polymorph B - Google Patents

N-(2-aminophenyl)-4[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamid e(MS-275)polymorph B

Info

Publication number
GB0907347D0
GB0907347D0 GBGB0907347.9A GB0907347A GB0907347D0 GB 0907347 D0 GB0907347 D0 GB 0907347D0 GB 0907347 A GB0907347 A GB 0907347A GB 0907347 D0 GB0907347 D0 GB 0907347D0
Authority
GB
United Kingdom
Prior art keywords
benzamid
polymorph
aminophenyl
methoxycarbonyl
aminomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0907347.9A
Other versions
GB2462893B (en
GB2462893A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of GB0907347D0 publication Critical patent/GB0907347D0/en
Publication of GB2462893A publication Critical patent/GB2462893A/en
Application granted granted Critical
Publication of GB2462893B publication Critical patent/GB2462893B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
GB0907347A 2008-08-29 2009-04-29 N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B Active GB2462893B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9304608P 2008-08-29 2008-08-29

Publications (3)

Publication Number Publication Date
GB0907347D0 true GB0907347D0 (en) 2009-06-10
GB2462893A GB2462893A (en) 2010-03-03
GB2462893B GB2462893B (en) 2010-10-13

Family

ID=40791975

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0907347A Active GB2462893B (en) 2008-08-29 2009-04-29 N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B

Country Status (2)

Country Link
CU (1) CU24049B1 (en)
GB (1) GB2462893B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2977492B1 (en) * 2011-07-04 2013-07-05 Servier Lab NOVEL ASSOCIATION BETWEEN N-HYDROXY-4- {2- [3- (N, N-DIMETHYLAMINOMETHYL) BENZOFURAN-2-YLCARBONYLAMINO] ETHOXY} BENZAMIDE AND FOLFOX

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
JP2001064177A (en) * 1999-08-16 2001-03-13 Schering Ag Pharmaceutical preparation including benzamide derivative as ingredient
JP4360660B2 (en) * 1999-11-09 2009-11-11 三井化学株式会社 Purification method of monoacylphenylenediamine derivatives
PE20050206A1 (en) * 2003-05-26 2005-03-26 Schering Ag PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF HISTONE DEACETILASE

Also Published As

Publication number Publication date
CU20110044A7 (en) 2011-12-28
GB2462893B (en) 2010-10-13
CU24049B1 (en) 2014-12-26
GB2462893A (en) 2010-03-03

Similar Documents

Publication Publication Date Title
SI2350005T1 (en) N-(2-AMINOPHENYL)-4-?áN-(PYRIDINE-3-YL)-METHOXYCARBONYL-AMINOMETHYL?å-BENZAMIDE (MS-275)POLYMORPH B
EP2238545A4 (en) Video quality measures
EP2104985A4 (en) Method for transmitting voip packet
EP2231096A4 (en) Mobility aid
EP2122982A4 (en) Lightweight mobility architecture
GB0820920D0 (en) Codec apparatus
EP2163055A4 (en) Mobility plane architecture for telecommunications system
HK1144070A1 (en) Peptide deformylase inhibitors
EP2062415A4 (en) Location architecture for large scale networks
AU321031S (en) Broom block
PL2340253T3 (en) Processes for the selective amination of ketomorphinans
GB0701574D0 (en) Wave-dissipating block
PL2268408T3 (en) Showerhead
ZA201101275B (en) Teaching aid for accounting
GB0907347D0 (en) N-(2-aminophenyl)-4[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamid e(MS-275)polymorph B
HK1137851A1 (en) Switching apparatus
GB0811758D0 (en) Mobility aid
GB2445830B (en) Distributed conferencing via PBX-Conference bridge link
SI2206711T1 (en) Tetomilast polymorph
GB0608075D0 (en) Anti-tangle device
GB2452580B (en) Spraying apparatus
GB0807522D0 (en) Switching apparatus
IL185505A0 (en) Current-monitoring apparatus
GB0725004D0 (en) Lysozyme inhibitors
HU3408U (en) Block

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130228 AND 20130306